CSBR
Champions Oncology, Inc.
Price Chart
No historical data available
Latest Quote
$4.93
-0.09 (-1.79%)
Current Price
| Previous Close | $5.02 |
| Open | $5.10 |
| Day High | $5.10 |
| Day Low | $4.93 |
| Volume | 5,142 |
Stock Information
| Shares Outstanding | 13.89M |
| Total Debt | $4.60M |
| Cash Equivalents | $4.87M |
| Revenue | $59.42M |
| Net Income | $-1.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $68.50M |
| EPS (TTM) | $-0.08 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Champions Oncology, Inc.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on CSBR.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $30,900,000 | $28,389,000 | $29,401,000 | $29,532,000 |
| Cost Of Revenue | $30,900,000 | $28,389,000 | $29,401,000 | $29,532,000 |
| Total Revenue | $59,425,000 | $56,944,000 | $50,155,000 | $53,870,000 |
| Operating Revenue | $59,425,000 | $56,944,000 | $50,155,000 | $53,870,000 |
| Expenses | ||||
| Total Expenses | $60,454,000 | $52,098,000 | $57,076,000 | $58,319,000 |
| Other Income Expense | $100,000 | $-220,000 | $-387,000 | $-818,000 |
| Other Non Operating Income Expenses | $211,000 | $73,000 | $48,000 | $-11,000 |
| Operating Expense | $29,554,000 | $23,709,000 | $27,675,000 | $28,787,000 |
| Selling And Marketing Expense | $9,318,000 | $7,545,000 | $7,064,000 | $7,002,000 |
| General And Administrative Expense | $11,152,000 | $9,339,000 | $11,067,000 | $10,240,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Normalized Income | $-1,108,400 | $4,932,470 | $-6,843,175 | $-4,697,470 |
| Net Income From Continuing And Discontinued Operation | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Total Operating Income As Reported | $-1,140,000 | $4,553,000 | $-7,356,000 | $-5,256,000 |
| Net Income Common Stockholders | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Net Income | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Net Income Including Noncontrolling Interests | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Net Income Continuous Operations | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Pretax Income | $-929,000 | $4,626,000 | $-7,308,000 | $-5,267,000 |
| Special Income Charges | $-111,000 | $-293,000 | $-435,000 | $-807,000 |
| Operating Income | $-1,029,000 | $4,846,000 | $-6,921,000 | $-4,449,000 |
| Gross Profit | $28,525,000 | $28,555,000 | $20,754,000 | $24,338,000 |
| Per Share | ||||
| Diluted EPS | $-0.08 | $0.33 | $-0.54 | $-0.39 |
| Basic EPS | $-0.08 | $0.34 | $-0.54 | $-0.39 |
| Other | ||||
| Tax Effect Of Unusual Items | $-44,400 | $-61,530 | $-2,175 | $-169,470 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $459,000 | $6,779,000 | $-4,619,000 | $-1,396,000 |
| Total Unusual Items | $-111,000 | $-293,000 | $-435,000 | $-807,000 |
| Total Unusual Items Excluding Goodwill | $-111,000 | $-293,000 | $-435,000 | $-807,000 |
| Reconciled Depreciation | $1,377,000 | $1,640,000 | $1,867,000 | $2,246,000 |
| EBITDA (Bullshit earnings) | $348,000 | $6,486,000 | $-5,054,000 | $-2,203,000 |
| EBIT | $-1,029,000 | $4,846,000 | $-6,921,000 | $-4,449,000 |
| Diluted Average Shares | $13,832,385 | $14,266,781 | $13,547,604 | $13,541,559 |
| Basic Average Shares | $13,832,385 | $13,659,786 | $13,547,604 | $13,541,559 |
| Diluted NI Availto Com Stockholders | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Tax Provision | $246,000 | $-75,000 | $-32,000 | $68,000 |
| Gain On Sale Of Ppe | $-111,000 | $-293,000 | $-435,000 | $0 |
| Research And Development | $9,084,000 | $6,825,000 | $9,544,000 | $11,545,000 |
| Selling General And Administration | $20,470,000 | $16,884,000 | $18,131,000 | $17,242,000 |
| Other Gand A | $11,152,000 | $9,339,000 | $11,067,000 | $10,240,000 |
| Write Off | - | - | $0 | $807,000 |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-08-31
Balance Sheet (Annual)
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,604,000 | $3,437,000 | $-2,238,000 | $4,301,000 |
| Total Assets | $26,989,000 | $32,344,000 | $26,132,000 | $34,311,000 |
| Total Non Current Assets | $7,770,000 | $9,986,000 | $12,493,000 | $14,854,000 |
| Other Non Current Assets | $212,000 | $196,000 | $185,000 | $15,000 |
| Goodwill And Other Intangible Assets | $335,000 | $335,000 | $335,000 | $335,000 |
| Current Assets | $19,219,000 | $22,358,000 | $13,639,000 | $19,457,000 |
| Other Current Assets | $1,169,000 | $1,369,000 | $1,495,000 | $1,328,000 |
| Receivables | $13,178,000 | $11,204,000 | $9,526,000 | $8,011,000 |
| Receivables Adjustments Allowances | $-1,057,000 | $-1,029,000 | $-1,301,000 | $-825,000 |
| Other Receivables | $7,528,000 | $5,398,000 | $5,941,000 | $4,993,000 |
| Accounts Receivable | $6,707,000 | $6,835,000 | $4,886,000 | $3,843,000 |
| Cash Cash Equivalents And Short Term Investments | $4,872,000 | $9,785,000 | $2,618,000 | $10,118,000 |
| Cash And Cash Equivalents | $4,872,000 | $9,785,000 | $2,618,000 | $10,118,000 |
| Cash Financial | $4,872,000 | $9,785,000 | $2,618,000 | $10,118,000 |
| Prepaid Assets | - | - | - | - |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,512,000 | $6,105,000 | $7,430,000 | $8,599,000 |
| Long Term Debt And Capital Lease Obligation | $2,992,000 | $4,634,000 | $6,093,000 | $7,391,000 |
| Current Debt And Capital Lease Obligation | $1,520,000 | $1,471,000 | $1,337,000 | $1,208,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $22,921,000 | $28,572,000 | $28,035,000 | $29,675,000 |
| Total Non Current Liabilities Net Minority Interest | $2,999,000 | $4,719,000 | $6,494,000 | $7,942,000 |
| Other Non Current Liabilities | $7,000 | $85,000 | $401,000 | $551,000 |
| Current Liabilities | $19,922,000 | $23,853,000 | $21,541,000 | $21,733,000 |
| Other Current Liabilities | $79,000 | $135,000 | $150,000 | $145,000 |
| Current Deferred Liabilities | $8,828,000 | $15,443,000 | $12,094,000 | $12,776,000 |
| Payables And Accrued Expenses | $9,495,000 | $6,804,000 | $7,960,000 | $7,604,000 |
| Payables | $6,903,000 | $4,248,000 | $5,800,000 | $5,334,000 |
| Accounts Payable | $6,903,000 | $4,248,000 | $5,800,000 | $5,334,000 |
| Equity | ||||
| Common Stock Equity | $3,939,000 | $3,772,000 | $-1,903,000 | $4,636,000 |
| Total Equity Gross Minority Interest | $4,068,000 | $3,772,000 | $-1,903,000 | $4,636,000 |
| Stockholders Equity | $3,939,000 | $3,772,000 | $-1,903,000 | $4,636,000 |
| Retained Earnings | $-81,067,000 | $-79,892,000 | $-84,593,000 | $-77,317,000 |
| Other | ||||
| Ordinary Shares Number | $13,886,826 | $13,705,570 | $13,593,766 | $13,544,228 |
| Share Issued | $13,886,826 | $13,705,570 | $13,714,099 | $13,558,650 |
| Tangible Book Value | $3,604,000 | $3,437,000 | $-2,238,000 | $4,301,000 |
| Invested Capital | $3,939,000 | $3,772,000 | $-1,903,000 | $4,636,000 |
| Working Capital | $-703,000 | $-1,495,000 | $-7,902,000 | $-2,276,000 |
| Capital Lease Obligations | $4,512,000 | $6,105,000 | $7,430,000 | $8,599,000 |
| Total Capitalization | $3,939,000 | $3,772,000 | $-1,903,000 | $4,636,000 |
| Minority Interest | $129,000 | $0 | - | - |
| Treasury Stock | $708,000 | $708,000 | $708,000 | $74,000 |
| Additional Paid In Capital | $85,700,000 | $84,358,000 | $83,384,000 | $82,013,000 |
| Capital Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Common Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Long Term Capital Lease Obligation | $2,992,000 | $4,634,000 | $6,093,000 | $7,391,000 |
| Current Deferred Revenue | $8,828,000 | $15,443,000 | $12,094,000 | $12,776,000 |
| Current Capital Lease Obligation | $1,520,000 | $1,471,000 | $1,337,000 | $1,208,000 |
| Current Accrued Expenses | $2,592,000 | $2,556,000 | $2,160,000 | $2,270,000 |
| Goodwill | $335,000 | $335,000 | $335,000 | $335,000 |
| Net PPE | $7,223,000 | $9,455,000 | $11,973,000 | $14,504,000 |
| Accumulated Depreciation | $-12,892,000 | $-11,688,000 | $-10,391,000 | $-8,630,000 |
| Gross PPE | $20,115,000 | $21,143,000 | $22,364,000 | $23,134,000 |
| Leases | $361,000 | $317,000 | $317,000 | $111,000 |
| Construction In Progress | $2,098,000 | $2,012,000 | $1,891,000 | $2,967,000 |
| Other Properties | $15,162,000 | $16,403,000 | $17,758,000 | $17,708,000 |
| Machinery Furniture Equipment | $2,494,000 | $2,411,000 | $2,398,000 | $2,348,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $120,333 | $14,422 |
Fetched: 2026-08-31
Cash Flow Statement (Annual)
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,036,000 | $6,997,000 | $-6,973,000 | $1,100,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,472,000 | $7,386,000 | $-6,137,000 | $3,972,000 |
| Cash Flow From Continuing Operating Activities | $-4,472,000 | $7,386,000 | $-6,137,000 | $3,972,000 |
| Operating Gains Losses | $111,000 | $293,000 | $435,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-564,000 | $-389,000 | $-836,000 | $-2,872,000 |
| Investing Cash Flow | $-540,000 | $-389,000 | $-836,000 | $-2,872,000 |
| Cash Flow From Continuing Investing Activities | $-540,000 | $-389,000 | $-836,000 | $-2,872,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $99,000 | $170,000 | $-527,000 | $11,000 |
| Cash Flow From Continuing Financing Activities | $99,000 | $170,000 | $-527,000 | $11,000 |
| Repurchase Of Capital Stock | - | $0 | $-634,000 | $-74,000 |
| Net Common Stock Issuance | - | $0 | $-634,000 | $-74,000 |
| Other | ||||
| Repayment Of Debt | $-135,000 | $-150,000 | $-146,000 | $0 |
| End Cash Position | $4,872,000 | $9,785,000 | $2,618,000 | $10,118,000 |
| Beginning Cash Position | $9,785,000 | $2,618,000 | $10,118,000 | $9,007,000 |
| Changes In Cash | $-4,913,000 | $7,167,000 | $-7,500,000 | $1,111,000 |
| Proceeds From Stock Option Exercised | $234,000 | $320,000 | $253,000 | $85,000 |
| Net Issuance Payments Of Debt | $-135,000 | $-150,000 | $-146,000 | $0 |
| Net Long Term Debt Issuance | $-135,000 | $-150,000 | $-146,000 | $0 |
| Long Term Debt Payments | $-135,000 | $-150,000 | $-146,000 | $0 |
| Net PPE Purchase And Sale | $-540,000 | $-389,000 | $-836,000 | $-2,872,000 |
| Sale Of PPE | $24,000 | $0 | - | - |
| Purchase Of PPE | $-564,000 | $-389,000 | $-836,000 | $-2,872,000 |
| Change In Working Capital | $-7,424,000 | $-802,000 | $-3,823,000 | $4,243,000 |
| Change In Other Working Capital | $-6,615,000 | $3,349,000 | $-683,000 | $1,706,000 |
| Change In Other Current Liabilities | $-1,586,000 | $-1,324,000 | $-1,169,000 | $-907,000 |
| Change In Other Current Assets | $-16,000 | $0 | $-169,000 | $0 |
| Change In Payables And Accrued Expense | $2,595,000 | $-1,354,000 | $356,000 | $2,320,000 |
| Change In Accrued Expense | $37,000 | $395,000 | $-109,000 | $-145,000 |
| Change In Payable | $2,558,000 | $-1,749,000 | $465,000 | $2,465,000 |
| Change In Account Payable | $2,558,000 | $-1,749,000 | $465,000 | $2,465,000 |
| Change In Prepaid Assets | $200,000 | $144,000 | $-167,000 | $-184,000 |
| Change In Receivables | $-2,002,000 | $-1,617,000 | $-1,991,000 | $1,308,000 |
| Changes In Account Receivables | $-2,002,000 | $-1,436,000 | $-1,991,000 | $1,308,000 |
| Other Non Cash Items | $1,374,000 | $1,172,000 | $1,066,000 | $952,000 |
| Stock Based Compensation | $1,237,000 | $654,000 | $1,118,000 | $864,000 |
| Provisionand Write Offof Assets | $28,000 | $-272,000 | $476,000 | $195,000 |
| Depreciation Amortization Depletion | $1,377,000 | $1,640,000 | $1,867,000 | $2,246,000 |
| Depreciation And Amortization | $1,377,000 | $1,640,000 | $1,867,000 | $2,246,000 |
| Gain Loss On Sale Of PPE | $111,000 | $293,000 | $435,000 | $0 |
| Net Income From Continuing Operations | $-1,175,000 | $4,701,000 | $-7,276,000 | $-5,335,000 |
| Common Stock Payments | - | $0 | $-634,000 | $-74,000 |
| Deferred Tax | - | $-181,000 | $0 | - |
| Deferred Income Tax | - | $-181,000 | $0 | - |
| Asset Impairment Charge | - | - | $0 | $807,000 |
Fetched: 2026-08-31